Milton Keynes University Hospital purchases second Versius system to bring robotic MAS to more patients

CMR Surgical (CMR) – the global surgical robotics business – has today announced that Milton Keynes University Hospital NHS Foundation Trust (MKUH) have installed their second Versius Surgical Robotic System.

Yourgene Health and Genetix launch first local non-invasive prenatal testing service in Colombia

Genetix will utilise Yourgene Health’s IONA Nx NIPT Workflow to deliver first NIPT service in region Service offers safe, fast and accurate prenatal testing to expectant parents

Manchester, UK, and Bogotá, Colombia, 2 October 2024:

Celebrating the Cambridge Tech Week Innovation Alley Award winners

We’re delighted to share news and reactions from our Cambridge Tech Week Innovation Alley Award winners for ‘Start-Up of the Year’ and the ‘People’s Choice’ Awards.

Nuclera strengthens team with three key appointments

Dr Gordon McInroy appointed as COO, Dr Tobias Ost as SVP Product Development, and Charu Maini as SVP of People

ERS Genomics and Université de Montréal sign CRISPR/Cas9 license agreement

License agreement provides Université de Montréal access to CRISPR gene editing technology for use across its platform services

ESMO 2024 review: Improving patient survival through innovations in oncology

European Society for Medical Oncology (ESMO) Congress 2024 was held in Barcelona, Spain, bringing together the global oncology community to share the latest data, innovations, and advancements in cancer care.

Inspiration, innovation, insights, impact, and collaboration – key takeaways from Cambridge Tech Week 2024

Cambridge Tech Week 2024 (CTW24), held from September 9 to 13, closed on a high, with young talents engaging with the dynamic Cambridge tech ecosystem, fuelling their tech aspirations.

Sphere Fluidics announces Cyto-Mine Chroma to accelerate and streamline workflows across expanded applications in biotherapeutic discovery and development

Next generation of industry-leading Cyto-Mine platform will offer new capabilities to optimize single-cell analysis workflow efficiency Opens up new, multiplexed assays and applications for antibody discovery and cell line development, and allows entry into

Know your customer: strategic considerations for AI-powered provider segmentation

Published in Life Science Leader, CRA’s Robert Broadnax, Eddie Li and Brian Carpenter co-authored an article “Know Your Customer: Strategic Considerations for AI-Powered Provider Segmentation,” focused on the strategic considerations for drug manufacturers in developing an AI-powered provider seg

Psoriasis patient source of business for major IL-17 agents

Source of business for leading IL-17 agents in psoriasis varies significantly by brand. While the majority of Cosentyx patients are previously treated with a TNF inhibitor, a sizable portion of Taltz patients have tried another IL-17 agent before starting Taltz.

Implications of the Inflation Reduction Act for cancer medicine development

The Inflation Reduction Act (IRA) Medicare Drug Price Negotiation Program (MDPNP) directs the Secretary of Health and Human Services (HHS) to set a maximum price for certain drugs in Medicare.

Owlstone Medical partners with the FDA to advance the identification of volatile organic compounds in breath and expand its Breath Biopsy VOC Atlas.

Collaboration will develop analytical methods to improve the identification of specific chemicals in complex gaseous mixtures Owlstone will use the developed methods and techniques to enhance its work in the field of breath-based biomarkers of disease

Introducing Gluetacs Therapeutics to the UK market

Gluetacs Therapeutics (www.gluetacs.com), a pioneering biotech company located in the innovative Lin-gang Special Area of China (Shanghai) Pilot Free Trade Zone, is making significant strides in the field of targeted protein degradation, both in molecular glue (GLUE) and bifunctional degrader (GLUETAC). As a member of the Lingang Cambridge Network, Gluetacs is committed to advancing its cutting…

Cambridge Independent Business Awards 2024

We are thrilled to announce that Costello Medical won two prestigious awards at the inaugural Cambridge Independent Business Awards 2024! Congratulations to all the winners and finalists from the other categories and a big thank you to the Cambridge Independent for putting on such a wonderful gala at King’s College, Cambridge to celebrate the Cambridge business community’s successes!

FUJIFILM Irvine Scientific Adds Key Products To Its Life Sciences Portfolio From FUJIFILM Wako Chemicals U.S.A.

Additional products in lab automation, lab chemicals and LAL expand complete solutions available directly from FUJIFILM Irvine Scientific to customers in US and Europe Sales agreement aligns business and commercial operations to maximize customer benefit

Isogenica Ltd. and Axxam S.p.A. Announce Collaboration to Provide Unique VHH Antibody Discovery Solutions

Axxam S.p.A. and Isogenica Ltd. have announced a partnership to bring together functional bioassay capabilities with unique antibody discovery solutions for biotechnology and pharmaceutical clients.

Hospital prosthetics service moves to high-tech new home

An Addenbrooke’s service that offers vital support for amputees and others officially opened on the 23rd Sept at a high-tech new home after nearly quarter of a century at the hospital.

Have a heart – learn CPR, says MP

In advance of World Heart Day, Daniel Zeichner, Member of Parliament for Cambridge, tried out RevivR, a new CPR training tool, at a British Heart Foundation (BHF) shop in Cambridge on Friday 20 September to highlight the charity's vital work in combating heart and circulatory diseases.

impulse’s next-gen female entrepreneurs eye up $1trillion FemTech sector

With the FemTech market set to be worth $1trillion by 2027 (McKinsey & Company), impulse, the University of Cambridge’s unique entrepreneurship programme, has seen a sharp rise in the number of participants contributing novel innovations to this exciting sector.

Transforming healthcare: the power of purpose-led partnerships

In this episode, ⁠Dr Bipin Patel⁠ sits down with ⁠Samuel Hollis⁠, Coun

Enterprise Therapeutics granted ‘rare pediatric disease designation’ in the US for novel cystic fibrosis investigational therapy ETD001

ETD001 is a novel, first in class blocker of the epithelial sodium channel (ENaC) aimed at treating people with cystic fibrosis without current effective therapies ETD001 commenced Phase 2 clinical trials in July 2024, expected to complete in 2025

Nxera Pharma receives approval of QUVIVIQ (daridorexant) in Japan for the treatment of insomnia

The approval of QUVIVIQ™, a novel dual orexin receptor antagonist, is based on robust clinical efficacy and safety data, including from a Phase 3 trial in Japan that met all primary and secondary endpoints Plans to make QUVIVIQ available as soon as possible to insomnia patients in Japan are underway Tokyo, Japan and Cambridge, UK, 24 September 2024 – Nxera Pharma Co., Ltd. – formerly known as…

Takeda’s Qdenga® - more campaigns needed before single-dose products arrive

This month VacZine Analytics, a specialist in infectious diseases and vaccines commercial analysis publishes a brand-new global analysis of the dengue endemic vaccines market.

Steritas’ Pediatric Glucocorticoid Toxicity Index used by Alder Hey and Liverpool Trials Centre to assess steroid toxicity in children with juvenile idiopathic arthritis

Study will allow researchers to assess the outcomes of intravenous and oral glucocorticoid protocols in children

Broken String Biosciences appoints Laurence Reid and Brad Crutchfield to its Board of Directors

Laurence Reid joins as Chairman, previously Decibel Therapeutics, Warp Drive Bio, Alnylam, and Third Rock Ventures Brad Crutchfield appointed as Non-Executive Director, previously 10x Genomics, QIAGEN, Illumina, and Bio-Rad Laboratories

C